Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05497479 · ClinicalTrials.gov registry record · Phase 1
Study Evaluating Techniques for Measuring Tear Production
A Phase 1 study of Dry Eye Disease, sponsored by Aerie Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05497479 is a Phase 1 study of Dry Eye Disease that has completed, run by Aerie Pharmaceuticals. The registered enrollment target is 40 participants, below the 254-participant average among 33 other Dry Eye Disease trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05497479, a Phase 1 study of Dry Eye Disease, has completed, sponsored by Aerie Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a vehicle-controlled, masked, randomized study conducted at a single site in the United States. All participants enrolled will have Dry Eye Disease (DED). The study will consist of 2 Visits. At Visit 1, eligibility will be assessed at Screening. All eligible subjects will then be enrolled and randomized to one of two treatment groups (1:1): active (0.003% AR-15512) or control (AR-15512 vehicle). Subjects in each treatment group will then be randomized 1:1 to which Visit (Visit 1 or 2) anesthetic will be used with the Schirmer test.
Conditions Studied
Interventions
- DRUG 0.003% AR-15512 to be administered in both eyes
- DRUG Vehicle to be administered in both eyes
Study Locations (1)
California
- Eye Research Foundation - Newport Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-12-09 |
| Est. Completion | 2021-12-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05497479
The ClinicalTrials.gov registry entry for NCT05497479 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 254-participant average among 33 other Dry Eye Disease trials with a reported enrollment target (84% lower). The listed sponsor is Aerie Pharmaceuticals, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dry Eye Disease appearing as the primary indexed condition, and to 2 interventions - of which 0.003% AR-15512 to be administered in both eyes is the first listed.
NCT05497479 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05497479 about?
NCT05497479 is a clinical study titled "Study Evaluating Techniques for Measuring Tear Production". This will be a vehicle-controlled, masked, randomized study conducted at a single site in the United States. All participants enrolled will have Dry Eye Disease (DED). The study will consist of 2 Visits. At Visit 1, eligibility will be assessed at Screening. All eligible subjects will then be enroll...
What is the current status of trial NCT05497479?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2021-12-09. Estimated completion is 2021-12-10.
What conditions does trial NCT05497479 study?
This clinical trial studies the following conditions: Dry Eye Disease.
What interventions are being tested in trial NCT05497479?
The interventions under investigation include: 0.003% AR-15512 to be administered in both eyes (DRUG), Vehicle to be administered in both eyes (DRUG).
Who is sponsoring clinical trial NCT05497479?
This trial is sponsored by Aerie Pharmaceuticals, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05497479 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease
COMPLETED · Phase 1
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
COMPLETED · Phase 1
-
Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.
COMPLETED · Phase 1
-
A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease
RECRUITING · Phase 3
-
A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment
RECRUITING · Phase 4
-
Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.